Meditor Pharmaceuticals Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Meditor Pharmaceuticals General Information

Description

Manufacturer of medical technology and therapeutic equipment. The company is a bio pharmaceutical company dedicated to the development and commercialization of proprietary products for the therapeutic management of acute and chronic hypo-tension and hypo tension related disorders.

Contact Information

Website
www.meditorpharma.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 5352 North West 35th Avenue
  • Fort Lauderdale, FL 33309
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
American Medical Technologies
Vertical(s)
Manufacturing
Corporate Office
  • 5352 North West 35th Avenue
  • Fort Lauderdale, FL 33309
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Meditor Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Meditor Pharmaceuticals‘s full profile, request access.

Request a free trial

Meditor Pharmaceuticals Patents

  • 32

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Meditor Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2167050-A1 Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives Inactive 13-Jun-2007
US-20100285127-A1 Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives Inactive 13-Jun-2007
US-20090186854-A1 S-alkylisothiouronium derivatives for the treatment of inflammatory diseases Inactive 23-Mar-2006
CA-2621582-A1 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients Inactive 06-Sep-2005
EP-1933822-A1 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients Inactive 06-Sep-2005 A61K31/145
To view Meditor Pharmaceuticals’s complete patent history, request access »

Meditor Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Meditor Pharmaceuticals FAQs

  • Where is Meditor Pharmaceuticals headquartered?

    Meditor Pharmaceuticals is headquartered in Fort Lauderdale, FL.

  • What is the size of Meditor Pharmaceuticals?

    Meditor Pharmaceuticals has 2 total employees.

  • What industry is Meditor Pharmaceuticals in?

    Meditor Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Meditor Pharmaceuticals a private or public company?

    Meditor Pharmaceuticals is a Private company.

  • What is Meditor Pharmaceuticals’s current revenue?

    The current revenue for Meditor Pharmaceuticals is .

  • When was Meditor Pharmaceuticals acquired?

    Meditor Pharmaceuticals was acquired on 12-Mar-2009.

  • Who acquired Meditor Pharmaceuticals?

    Meditor Pharmaceuticals was acquired by American Medical Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »